Association between filaggrin null mutations and concomitant atopic dermatitis and contact allergy

Clinical and Experimental Dermatology

Volumn 36, Issue 5, 2011, Pages 467-472

  Carlsen, B C ^a   Thyssen, J P ^a   Menne T ^a   Meldgaard, M ^a   Linneberg, A ^b   Nielsen, N H ^c   Szecsi, P B ^a   Stender, S ^a   Johansen, J D ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Dermatology Clinic   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FILAGGRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CAUCASIAN; COMORBIDITY; CONTACT ALLERGY; CONTROLLED STUDY; DELETION MUTANT; DNA HYBRIDIZATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAND ECZEMA; HETEROZYGOTE; HOMOZYGOTE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NULL ALLELE; ONSET AGE; PATCH TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, ATOPIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MALE; MIDDLE AGED; MUTATION; PATCH TESTS; PHENOTYPE; YOUNG ADULT;

EID: 79959329667     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2010.03994.x     Document Type: Article

References (26)

1. Sandilands A, Sutherland C, Irvine AD et al. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 2009; 122: 1285-94.
2. O'regan GM, Sandilands A, McLean WH et al. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2008; 122: 689-93.
3. Fallon PG, Sasaki T, Sandilands A et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 2009; 41: 602-8.
4. Nemoto-Hasebe I, Akiyama M, Nomura T et al. Clinical severity correlates with impaired barrier in filaggrin-related eczema. J Invest Dermatol 2009; 129: 682-9.
5. Rudikoff D, Lebwohl M. Atopic dermatitis. Lancet 1998; 351: 1715-21.
6. Ingordo V, D'Andria G, D'Andria C. Adult-onset atopic dermatitis in a patch test population. Dermatology 2003; 206: 197-203.
7. Lerbaek A, Kyvik KO, Ravn H et al. Incidence of hand eczema in a population-based twin cohort: genetic and environmental risk factors. Br J Dermatol 2007; 157: 552-7.
8. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441-6.
9. Brown SJ, McLean WH. Eczema genetics. Current state of knowledge and future goals. J Invest Dermatol 2009; 129: 543-52.
10. Barker JN, Palmer CN, Zhao Y et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol 2007; 127: 564-7.
11. van den Oord RA, Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ 2009; 339: b2433.
12. Brown SJ, Relton CL, Liao H et al. Filaggrin null mutations and childhood atopic eczema: a population-based case-control study. J Allergy Clin Immunol 2008; 121: 940-6.
13. Thyssen JP, Carlsen BC, Johansen JD et al. Filaggrin null-mutations may be associated with a distinct subtype of atopic hand eczema. Acta Derm Venereol 2010; 90: 528.
14. Carlsen BC, Andersen KE, Menne T et al. Characterization of the polysensitized patient: a matched case-control study. Contact Dermatitis 2009; 61: 22-30.
15. Thyssen JP, Johansen JD, Linneberg A et al. The association between null mutations in the filaggrin gene and contact sensitization to nickel and other chemicals in the general population. Br J Dermatol, 2010; 162: 1278-1285.
16. Williams HC. So How Do I Define Atopic Eczema? A Practical Manual for Researchers Wishing to Define Atopic Eczema. Nottingham: University of Nottingham, 1996.
17. Sandilands A, Terron-Kwiatkowski A, Hull PR et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 2007; 39: 650-4.
18. Weidinger S, Rodriguez E, Stahl C et al. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J Invest Dermatol 2007; 127: 724-6.
19. Bisgaard H, Halkjaer LB, Hinge R et al. Risk analysis of early childhood eczema. J Allergy Clin Immunol 2009; 123: 1355-60.
20. Vercelli D. Of flaky tails and itchy skin. Nat Genet 2009; 41: 512-13.
21. Novak N, Bieber T. Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 2003; 112: 252-62.
22. Schmid-Grendelmeier P, Simon D, Simon HU et al. Epidemiology, clinical features, and immunology of the 'intrinsic' (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis). Allergy 2001; 56: 841-9.
23. Forsbeck M, Hovmark A, Skog E. Patch testing, tuberculin testing and sensitization with dinitrochlorobenzene and nitrosodimethylanilini of patients with atopic dermatitis. Acta Derm Venereol 1976; 56: 135-8.
24. Uehara M, Sawai T. A longitudinal study of contact sensitivity in patients with atopic dermatitis. Arch Dermatol 1989; 125: 366-8.
25. Muller S, Marenholz I, Lee YA et al. Association of filaggrin loss-of-function-mutations with atopic dermatitis and asthma in the Early Treatment of the Atopic Child (ETAC) population. Pediatr Allergy Immunol 2009; 20: 358-61.
26. Williams HC, Burney PG, Pembroke AC et al. The UK Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol 1994; 131: 406-16.